News

Press Releases

Current News and Historical Highlights

ALL
ALL
2026
2025
2024
2023
2022
2021
2020
2019
2018
2015
2014
Previous
Aug 31, 2026

Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients

Jun 17, 2026

Veloxis Pharmaceuticals Showcases Research at the 2026 American Transplant Congress

Apr 22, 2026

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

Apr 15, 2026

Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026

Mar 30, 2026

Calliditas Therapeutics AB to Present Exploratory Biomarker and Post-Hoc NefIgArd Analyses at the World Congress of Nephrology

Feb 25, 2026

Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases

Feb 24, 2026

Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

Feb 4, 2026

Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex Virus at TANDEM

US-AKTX-2600007 V1.0 6/26